Blood marker for late infection in preterm babies
Part of Genetic & congenital, Infections clinical trials.
This study tests a new blood marker (called MDW) to help doctors quickly spot late-onset sepsis in preterm babies. If it works, it could lead to faster treatment for infections in premature infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 37 weeks of pregnancy.
- Your baby must be at least 3 days (72 hours) old when joining the study.
- Your baby must have signs that could mean a late infection, such as fever, breathing problems, feeding issues, or being very sleepy or fussy.
- Your baby cannot have had an early infection (in the first 72 hours of life).
- Your baby cannot have major birth defects, chromosome problems, metabolic disorders, severe lack of oxygen at birth, or surgical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two substances in the blood (endocan and copeptin) to see if they can help doctors understand breathing problems in premature babies. It may lead to better ways to care for these infants.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study tests a faster way to check premature babies for infection using a small blood sample taken shortly after birth. It aims to help doctors detect and treat infections earlier.
This study is testing whether a special blood test can help predict sepsis earlier in people who come to the emergency department. It might help get faster treatment and better outcomes.
Hear when a new Late Onset Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.